L’or�al Groupe Partners With Abolis and Evonik to Scale Development of Next-Generation Bio-Based Ingredients
L'Or�al announces a tri-party agreement with biotech innovator, Abolis Biotechnologies and global specialty manufacturer, Evonik, to enable the discovery, development